跳至主要内容
临床试验/CTRI/2022/05/042739
CTRI/2022/05/042739尚未招募3 期

EFFICACY OF VIRECHANA, DASHAMOOLA KSHEERA BASTI ALONG WITH PANCHATIKTAGHRUTA GUGGULU AND GANDHARVAHASTADI KASHAYA ORALLY IN THE MANAGEMENT OF ENDOMETRIOSIS- A SINGLE ARM OPEN LABELLED CLINICAL TRIA

Institute of Teaching and Research in Ayurveda Jamnagar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.patients either asymptomatic or having clinical signs and symptoms of endometriosis
  • 2.patients eligible for Virechana karma and Basti karma
  • 3.patients having CA-125 level <500 U/mL
  • 4.women with Hb >7 gm%

排除标准

  • 1.patient having chocolate cyst size greater than or equal to 7 cm as per USG report
  • 2.pregnant women with endometriosis
  • 3.women with Hb <7 gm%
  • 4.suspected carcinoma of reproductive tract
  • 5.patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases
  • 6.congenital anomaly of reproductive tract
  • 7.patients with history of cardiac diseases, chronic liver disease, uncontrolled hypertension (systolic BP above 160 & Diastolic above 100 mmHg), uncontrolled diabetes mellitus (above the range of 160 mg/dl-RBS)
  • 8.patients not eligible for Virechana karma and Basti
  • 9.patients having CA_125 level >500 U/M

研究者

发起方
Institute of Teaching and Research in Ayurveda Jamnagar

相似试验